Moderna (MRNA)

Moderna (MRNA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• MRNA last traded at $225.79, 1.84% on the day.
• Moderna: market cap $88.52B, P/E -27.8, revenue $2.23B over the last four quarters, next earnings 2026-11-06.
• Over the past year MRNA returned 702.38%; year to date 665.65%.

Updated 2026-11-02 17:50 UTC